Danish health authorities have approved treatment with Merck & Co Inc's molnupiravir tablet for Covid-19 patients at risk of serious illness, including the elderly.

The medication has yet to be approved by the European Medical Agency, which in late November started reviewing USdrugmaker Merck's experimental Covid-19 antiviral pill for adults and said it could issue an opinion within weeks.